Patients' experience of communication and handling of symptomatic adverse events in breast cancer patients receiving adjuvant chemotherapy

Christina Witt Bæksted, Aase Nissen, Ann S Knoop, Helle Pappot, Christina Witt Bæksted, Aase Nissen, Ann S Knoop, Helle Pappot

Abstract

Background: The study is based on a national cluster randomized trial investigating the effect of electronic patient-reported outcomes (ePRO) on treatment outcomes in breast cancer patients receiving adjuvant chemotherapy. All 13 oncology departments (11 clusters) treating breast cancer patients in Denmark were randomized to use electronic patient-reported outcomes with real-time clinician feedback (ePRO arm) to track symptoms or usual care for eliciting symptoms using a short paper tracking list (usual care arm). The impact of ePRO on clinical outcomes were examined, which is reported elsewhere. The purpose of the present study was to examine patient-reported experience measure (PREM) regarding communication and handling of side effects/symptoms.

Methods: For this sub-study, patient representatives were involved in the development of a PREM questionnaire. Patients enrolled in the cluster randomized trial completed the PREM questionnaire at their last treatment visit. Semi-structured telephone-interviews were performed with a subgroup of patients. The interviews were based on an interview guide comprised of the questions from the PREM questionnaire and aimed to elaborate on the PREM questionnaire data.

Results: A 12 item PREM questionnaire was developed in partnership with patient representatives. In total, 439 out of 682 patients (64.4%) included patients completed the PREM questionnaire. Telephone semi-structured interviews were performed with 22 patients. In total, 52% (ePRO arm) and 65% (usual care arm) reported having talked with the oncologist/nurse about their responses in the tracking systems before each chemotherapy cycle. Fewer patients in the ePRO arm compared to the usual care arm experienced side effects/symptoms not included in the side effect questionnaire. Patients experienced high satisfaction with oncologists' and nurses' handling of side effects/symptoms.

Conclusions: Patients experienced high satisfaction with oncologists' and nurses' handling of chemotherapy adverse events. The study indicates a need for a more comprehensive side effect questionnaire as tracking system covering more symptoms than the one used in usual care today.

Trial registration: Clinicaltrials.gov identifier NCT02996201. Registered 19 December 2016, retrospectively registered.

Keywords: Breast cancer; Chemotherapy; Patient involvement; Patient-reported experience measures; Side effects surveillance.

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

© The Author(s). 2019.

References

    1. Basch E, Bennett A, Pietanza MC. Use of patient-reported outcomes to improve the predictive accuracy of clinician-reported adverse events. J Natl Cancer Inst. 2011;103(24):1808–1810. doi: 10.1093/jnci/djr493.
    1. Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–565. doi: 10.1200/JCO.2015.63.0830.
    1. Basch E., Reeve B. B., Mitchell S. A., Clauser S. B., Minasian L. M., Dueck A. C., Mendoza T. R., Hay J., Atkinson T. M., Abernethy A. P., Bruner D. W., Cleeland C. S., Sloan J. A., Chilukuri R., Baumgartner P., Denicoff A., St. Germain D., O'Mara A. M., Chen A., Kelaghan J., Bennett A. V., Sit L., Rogak L., Barz A., Paul D. B., Schrag D. Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) JNCI Journal of the National Cancer Institute. 2014;106(9):dju244–dju244. doi: 10.1093/jnci/dju244.
    1. Di Maio Massimo, Basch Ethan, Bryce Jane, Perrone Francesco. Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. Nature Reviews Clinical Oncology. 2016;13(5):319–325. doi: 10.1038/nrclinonc.2015.222.
    1. Kluetz PG, Chingos DT, Basch EM, Mitchell SA. Patient-reported outcomes in cancer clinical trials: measuring symptomatic adverse events with the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Am Soc Clin Oncol Educ Book. 2016;35:67–73. doi: 10.1200/EDBK_159514.
    1. Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197–198. doi: 10.1001/jama.2017.7156.
    1. Yang LY, Manhas DS, Howard AF, Olson RA. Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communication. Support Care Cancer. 2018;26(1):41–60. doi: 10.1007/s00520-017-3865-7.
    1. Pappot H, Baeksted C, Knoop A, Johansen C, Mitchell SA, Nissen A. Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE). Breast J. 2019; In press.
    1. Gordon L., Dickinson A., Offredy M., Smiddy J. A research note on the benefit of patient and public involvement in research: The experience of prostate cancer patients regarding information in radiotherapy. Radiography. 2017;23(2):167–170. doi: 10.1016/j.radi.2017.02.004.
    1. Strasser F, Blum D, von Moos R, Cathomas R, Ribi K, Aebi S, et al. The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06) Ann Oncol. 2016;27(2):324–332. doi: 10.1093/annonc/mdv576.
    1. Greenhalgh J, Gooding K, Gibbons E, Dalkin S, Wright J, Valderas J, et al. How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis. J Patient Rep Outcomes. 2018;2:42. doi: 10.1186/s41687-018-0061-6.
    1. Tolstrup LK, Pappot H, Zangger G, Bastholt L, Zwisler AD, Dieperink KB. Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback form. Health Qual Life Outcomes. 2018;16(1):77. doi: 10.1186/s12955-018-0900-4.
    1. Crompton S. PROMs put patients at the heart of research and care. , System & Services, 2018;81:54-60. Available at .

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa